Kieran Gallahue - Feb 23, 2024 Form 4 Insider Report for Edwards Lifesciences Corp (EW)

Role
Director
Signature
Linda J. Park, Attorney-in-Fact
Stock symbol
EW
Transactions as of
Feb 23, 2024
Transactions value $
-$7,804
Form type
4
Date filed
2/26/2024, 05:52 PM
Previous filing
May 25, 2023
Next filing
May 9, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EW Common Stock Options Exercise $260K +7.06K +190.65% $36.86 10.8K Feb 23, 2024 Direct
transaction EW Common Stock Gift $0 -7.06K -65.59% $0.00 3.7K Feb 23, 2024 Direct
transaction EW Common Stock Gift $0 +7.06K +11.16% $0.00 70.3K Feb 23, 2024 By Trust
transaction EW Common Stock Sale -$268K -3.06K -4.35% $87.61 67.2K Feb 23, 2024 By Trust F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EW Director Stock Option (Right to Acquire) Options Exercise $0 -7.06K -100% $0.00* 0 Feb 23, 2024 Common Stock 7.06K $36.86 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $87.5908 to $87.6210. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.

Remarks:

This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.